PLEASE LOG IN
You must be logged in to complete the evaluation.
NOTE: Log in with your RNS account to take the evaluation
(this may differ from the login used to access the live event and OnDemand)
Thank you for attending and participating in the Virtual 2021 14th Annual Rheumatology Nurses Society (RNS) Conference. We hope that by attending you feel better equipped for day-to-day practice and treatment. To receive CNE credit / AAPA Category 1 CME credit, you must complete the course evaluation. A certificate will be generated immediately.
The Rheumatology Nurses Society is accredited with distinction as a provider of nursing continuing professional development by the American Nurses Credentialing Center’s Commission on Accreditation (Provider No. P0500).
Participants will receive up to 12.5 continuing nursing contact hours, including 5.0 pharmacotherapeutic contact hours, by actively participating in education sessions and completing an online evaluation upon completion of the program.
In support of improving patient care, AcademicCME is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
AcademicCME has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 12.5 AAPA Category 1 CME credits. PAs should only claim credit commensurate with the extent of their participation.
Educational Support Provided By: Bristol Myers-Squibb, Horizon Therapeutics USA, Inc., Janssen Biotech, Inc. administered by Janssen Scientific Affairs, LLC, and AbbVie
© 2021. This CNE-certified activity is held as copyrighted © by Rheumatology Nurses Society. Through this notice, the Rheumatology Nurses Society grants permission of its use for educational purposes only. These materials may not be used, in whole or in part, for any commercial purposes without prior permission in writing from the copyright owner(s).